MacroGenics
Nathalie Gerassimov is an accomplished scientist currently serving as a Dev Scientist II at MacroGenics, Inc., where work focuses on cell culture process development and optimization. With significant experience as a Postdoctoral Associate at The Carnegie Institution of Washington, Nathalie studied adult stem cell mechanisms through skeletal muscle regeneration in mice. Contributions to ASBMB Today as a contributor involved writing articles on scientific topics and highlighting scientists' achievements. Nathalie's earlier roles include research internships at MedImmune and the Milken Institute, where research on monoclonal antibody processes and various programmatic topics were undertaken, respectively. Educational background includes a Ph.D. from The Johns Hopkins University School of Medicine, a B.A. in Biochemistry from Smith College, and an Associate’s Degree from Cottey College.
This person is not in any offices
MacroGenics
1 followers
MacroGenics, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing monoclonal antibody-based therapeutics for the treatment of cancer, as well as various autoimmune disorders and infectious diseases. The Company devel...